• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRIUM MEDICAL CORPORATION C-QUR TACSHIELD; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRIUM MEDICAL CORPORATION C-QUR TACSHIELD; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number 31626
Health Effect - Clinical Codes Adhesion(s) (1695); Hernia (2240); Obstruction/Occlusion (2422); No Known Impact Or Consequence To Patient (2692)
Date of Event 03/13/2015
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A follow up report will be submitted upon the completion of the investigation into this event.This report is based upon allegations made in a potential lawsuit in which atrium medical would be named as a defendant.This report shall not be considered as an admission by atrium medical that the product described in the pre-suit claim and described herein are or were defective, or that it had any causal relationship to any injuries allegedly suffered by the claimant.
 
Event or Problem Description
This event is deemed reportable based on the allegations in a pre-suit claim which, while unsubstantiated, suggest that a reportable event may have occurred during use of atrium medicals mesh product.Claimant attributes unspecified complications to the mesh.Since this is a legal matter, the case has been turned over to legal counsel and further information obtained through investigation or discovery may fall under the attorney/client and/or work product privilege.However, atrium will supplement this report as appropriate if additional information comes to its attention.
 
Additional Manufacturer Narrative
A review of all manufacturing lot history and sterilization records was conducted.All in-process specifications and release criteria were met, including seal strength testing on both the pre-and-post-sterile packaging.Ball burst and suture retention testing was also conducted on the mesh at incoming and fourier transform infrared spectroscopy was performed on the cured coated mesh panels.
 
Event or Problem Description
Allegedly, the patient continued to develop new areas of herniation and failed repairs due to muscle wall weakness.
 
Event or Problem Description
Allegedly, plaintiff also experienced abdominal pain, adhesions, umbilical recurrent hernia, fat necrosis and small bowel obstruction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
C-QUR TACSHIELD
Common Device Name
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
ATRIUM MEDICAL CORPORATION
hudson NH
MDR Report Key5821653
Report Number1219977-2016-00153
Device Sequence Number1320286
Product Code FTL
UDI-Device Identifier00650862316261
UDI-Public00650862316261
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
K100076
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2012
Device Explanted Year2015
Reporter Type Manufacturer
Report Source other
Initial Reporter Occupation Attorney
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 07/14/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Physician
Device Expiration Date04/30/2014
Device Model Number31626
Device Catalogue Number31626
Device Lot Number10739855
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 07/14/2016
Supplement Date Received by ManufacturerNot provided
Not provided
11/22/2017
Initial Report FDA Received Date07/26/2016
Supplement Report FDA Received Date07/29/2016
08/31/2016
12/13/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age60 YR
-
-